Erdosteine - Edmond Pharma
Alternative Names: ALT 09; Asdigan; Biopulmin; Dostin; Dostol; Ectrin; Edirel; Erdomed; Erdopect; Erdos; Erdostin; Erdotin; Esteclin; Fluidasa; Flusten; KW 9144; Mucoflux; Mucofor; Mucotec; Mucothera; RV 144; Secresolv; Tusselin and Theovix; Tussol; VectrineLatest Information Update: 26 Dec 2022
At a glance
- Originator Edmond Pharma
- Developer Alitair Pharmaceuticals Inc; Edmond Pharma; Recipharm
- Class Anti-inflammatories; Antibronchitics; Expectorants; Small molecules; Thioglycolates; Thiophenes
- Mechanism of Action Antioxidants; Glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bronchitis
- Phase III Chronic obstructive pulmonary disease
- No development reported Bronchiectasis; COVID-19 pneumonia